A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content

A Microassay for 1,25-Dihydroxyvitamin D Not requiring High Performance Liquid Chromatography: Application to Clinical Studies*

Timothy A. Reinhardt, Ronald L. Horst, John W. Orf et al. · The Journal of Clinical Endocrinology & Metabolism · 1984 · 805 citations

Pharmacy, Pharmacology, Biopharmaceutics +15

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Eduardo Slatopolsky, Carol Weerts, J Thielan et al. · Journal of Clinical Investigation · 1984 · 686 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.

Eduardo Slatopolsky, Jane Finch, Masashi Denda et al. · Journal of Clinical Investigation · 1996 · 512 citations · Full text

Medicine, Endocrinology, Nephrology +17

Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.

Tally Naveh‐Many, Ruth Rahamimov, N Livni et al. · Journal of Clinical Investigation · 1995 · 410 citations · Full text

Medicine, Cell Biology, Endocrinology +16

Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis

Eduardo Slatopolsky, Carol Weerts, Silvia Lopez-Hilker et al. · New England Journal of Medicine · 1986 · 387 citations

Medicine, Nephrology, Pharmacotherapy +14